SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MERIGHI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.330
AS - Asia 8.702
EU - Europa 5.737
SA - Sud America 1.401
AF - Africa 147
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 33.338
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.994
SG - Singapore 3.446
CN - Cina 2.676
DE - Germania 1.322
BR - Brasile 1.157
UA - Ucraina 1.000
IT - Italia 980
HK - Hong Kong 841
TR - Turchia 728
GB - Regno Unito 584
VN - Vietnam 468
SE - Svezia 374
FI - Finlandia 364
RU - Federazione Russa 335
PL - Polonia 249
FR - Francia 186
CA - Canada 170
MX - Messico 138
AR - Argentina 99
IN - India 94
ID - Indonesia 92
NL - Olanda 89
BD - Bangladesh 78
JP - Giappone 73
ZA - Sudafrica 70
ES - Italia 60
BE - Belgio 47
IQ - Iraq 47
LT - Lituania 44
EC - Ecuador 39
CO - Colombia 22
MA - Marocco 21
VE - Venezuela 21
AE - Emirati Arabi Uniti 20
AT - Austria 20
CL - Cile 20
CZ - Repubblica Ceca 20
PK - Pakistan 18
PY - Paraguay 17
IL - Israele 14
KR - Corea 14
DZ - Algeria 13
UZ - Uzbekistan 13
KE - Kenya 12
AU - Australia 11
SA - Arabia Saudita 11
EG - Egitto 9
JO - Giordania 9
NP - Nepal 9
PE - Perù 9
IR - Iran 8
TN - Tunisia 8
UY - Uruguay 8
BO - Bolivia 6
EU - Europa 6
IE - Irlanda 6
AL - Albania 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
HN - Honduras 5
MY - Malesia 5
TW - Taiwan 5
CH - Svizzera 4
GT - Guatemala 4
KZ - Kazakistan 4
LV - Lettonia 4
NO - Norvegia 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
AM - Armenia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
MO - Macao, regione amministrativa speciale della Cina 3
NI - Nicaragua 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
AO - Angola 2
BH - Bahrain 2
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
HR - Croazia 2
IM - Isola di Man 2
LU - Lussemburgo 2
MD - Moldavia 2
MK - Macedonia 2
PA - Panama 2
PH - Filippine 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
Totale 33.318
Salva come PNG Salva come JPEG
Città #
Singapore 2.059
Woodbridge 1.755
Ashburn 1.651
Fairfield 1.554
Jacksonville 1.093
Chandler 1.077
Houston 1.054
Ann Arbor 878
Beijing 870
Hong Kong 835
Santa Clara 818
Seattle 661
Wilmington 641
Cambridge 532
Dallas 397
Izmir 365
Nanjing 335
Los Angeles 325
Ferrara 300
Princeton 255
Warsaw 229
Munich 219
Milan 210
Boardman 201
New York 183
Ho Chi Minh City 175
Shanghai 144
Dearborn 126
São Paulo 123
San Diego 115
Shenyang 111
Nanchang 105
Hanoi 94
Addison 90
Hefei 89
Tianjin 86
Falkenstein 85
London 85
Bremen 82
Turku 80
Mexico City 79
Helsinki 73
Jakarta 71
Buffalo 69
Changsha 64
Hebei 64
Frankfurt am Main 63
Montreal 63
Tokyo 63
Brooklyn 58
Chicago 57
Orem 52
Bologna 50
Jinan 47
Jiaxing 46
Brussels 45
Toronto 45
San Mateo 43
Poplar 41
San Francisco 41
Stockholm 41
Boston 39
Falls Church 39
Johannesburg 39
Moscow 39
Denver 37
Kunming 36
Atlanta 35
Mountain View 35
Phoenix 34
Zhengzhou 34
Norwalk 33
Rio de Janeiro 33
Council Bluffs 31
Manchester 31
The Dalles 31
Chennai 30
Guangzhou 28
Auburn Hills 26
Ningbo 26
Haiphong 25
Philadelphia 25
Redwood City 25
Brasília 24
Mumbai 24
Ankara 23
Columbus 23
Amsterdam 22
Belo Horizonte 22
Des Moines 20
San Jose 20
Dhaka 19
Orange 19
Rome 19
Verona 19
Nuremberg 18
Biên Hòa 17
Porto Alegre 17
Charlotte 16
Hangzhou 16
Totale 22.311
Salva come PNG Salva come JPEG
Nome #
Pharmacology of Adenosine Receptors: The State of the Art 300
A glance at adenosine receptors: Novel target for antitumor therapy 266
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 261
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 257
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 238
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 231
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 230
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 220
The A3 adenosine receptor: history and perspectives 219
Adenosine receptors and human melanoma 217
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 217
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 214
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 205
Adenosine receptor targeting in health and disease 204
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 201
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 201
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 200
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 200
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 197
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 197
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 196
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 196
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 194
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 192
Adenosine receptors and cancer 187
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 187
van't Hoff Based Thermodynamics 186
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 185
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 184
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 184
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 184
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 183
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 182
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 181
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 181
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 180
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 180
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 180
Pathological overproduction: the bad side of adenosine 178
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 178
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 177
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 176
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 174
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 174
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 174
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 173
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 173
Agonists and antagonists: Molecular mechanisms and therapeutic applications 173
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 172
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 172
Adenosine receptors in health and disease 172
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 171
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 170
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 170
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 169
A(2A) adenosine receptors in human peripheral blood cells 168
Adenosine and lymphocyte regulation 167
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 166
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 166
New potent and selective human adenosine A3 receptor antagonists. 165
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 164
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 164
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 163
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 161
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 160
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 160
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 160
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 159
The A3 adenosine receptor: An enigmatic player in cell biology 158
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 158
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 158
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 157
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 156
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 156
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 156
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 155
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 155
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 154
Targeting A3 and A2A adenosine receptors in the fight against cancer 154
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 153
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 152
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 152
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 152
New potent and selective human adenosine A3 receptor antagonists 150
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 149
Adenosine modulates HIF-1α, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells 149
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 147
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 147
MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS BY A3 ADENOSINE RECEPTORS 147
Adenosine in a human model of Hypoxic foam cells 146
[3H]-MRE 2029-F20, A Novel Selective Antagonist Radiolig and, for the Pharmacological and Biochemical Characterization of A2B Receptors. 146
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 146
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 145
Adenosine A2A receptors in human circulating blood elements 145
Recettori dell'adenosina in tessuti tumorali e in linee cellulari di colon:"focus" sul recettore A3. 144
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 144
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 143
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 142
Adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes 142
Cannabinoid CB2 receptor modulates microglial cell activation: role of ERK-1/2 Kinase signaling. 142
Totale 17.686
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.137
Totale 157.879
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.830 0 0 0 0 0 325 118 343 64 454 369 157
2021/20222.157 45 228 152 75 84 97 81 104 76 183 322 710
2022/20232.535 245 223 91 337 424 325 140 203 291 24 143 89
2023/20241.272 113 168 44 27 131 139 53 93 32 54 65 353
2024/20255.622 128 192 419 289 701 522 246 315 741 638 786 645
2025/20268.616 1.635 571 1.351 1.978 2.329 752 0 0 0 0 0 0
Totale 33.671